[Disease of respiratory organs in millers].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A F Abubikirov.
Explore the source record for details and available documents.
AIM: To study efficiency and safety of berodual in solution for inhalations delivered with the help of nebulizer in patients with exacerbation of chronic bronchitis (CB). MATERIALS AND METHODS: 12 patients with chronic bronchitis who had not responded to oral methylxantines in combination with expectorants received berodual for 10 days (1 ml 3 times a day). RESULTS: In the course of berodual treatment all the CB symptoms relieved and external respiration function improved. CONCLUSION: Berodual is effective as monotherapy of chronic obstructive bronchitis.
AIM: To study clinical efficiency of 12-month administration of berodual in chronic obstructive bronchitis (COB). MATERIALS AND METHODS: The trial entered 33 patients with at least 2-year history of COB and forced expiratory volume per 1 sec (FEV1) not less than 45% of normal value. RESULTS: The best response of clinical parameters and external respiration was observed throughout 3 weeks of berodual inhalations. Dyspnea and cough were cured by the end of the treatment in 40 and 26% of the patients, respectively. Exercise tolerance has improved, FEV1 has increased for the year from 71.9 to 79.1%. CONCLUSION: Long-term berodual monotherapy is able to inhibit progression of bronchial obstruction and symptoms of COB.
Explore the source record for details and available documents.
When tested in 115 patients with chronic obstructive bronchitis and bronchial asthma, low-energy laser radiation (Uzor unit) on bronchial obstruction had no direct broncholytic action. However, as a component of combined treatment, the above radiation produced a marked broncholytic effect due to its antiinflammatory action. Laser is recommended as a therapeutic modality in combined management of pulmonary obstruction.